Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

AERIE PHARMACEUTICALS INC (AERI)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21Mar-31-21Dec-31-20Sep-30-20
   10-Q10-Q8-K8-K10-Q10-Q10-K10-Q
Total revenues, net  207.1201.0194.1104.294.985.883.183.1
            Total revenues, net growth  118.2%134.4%133.5%25.3%16.4%8.1%19.0%39.2%
Costs and expenses:          
Cost of goods sold  10.513.0  24.825.925.320.5
Selling, general, and administrative  130.3136.7137.8136.8134.2132.9137.2137.6
Research and development  84.783.175.873.770.772.774.086.1
    Total costs and expenses  239.5246.8240.5237.8229.8231.7238.8253.1
    Loss from operations  -32.4-45.8-46.4-133.7-134.9-146.0-155.7-170.0
            Operating margin  -15.6%-22.8%-23.9%-128.4%-142.1%-170.2%-187.3%-204.6%
Other expense, net  -10.0-16.0 -27.4-26.2-24.7-22.2-22.0
    Loss before income taxes  -54.5-73.9  -161.1-170.6-177.9-192.1
Income tax expense  1.31.30.65.45.35.35.2 
    Net loss  -49.4-68.7-74.8-166.5-166.4-175.9-183.1-192.0
   
Net loss per common share—basic (in dollars per share)  ($1.05)($1.48)($1.63)($3.61)($3.61)($3.82)($3.98)($4.18)
Net loss per common share—diluted (in dollars per share)  ($1.07)($1.50)($1.65)($3.61)($3.61)($3.82)($3.98)($4.18)
   
Weighted average number of common shares outstanding—basic (in shares)  47.046.746.346.146.046.045.945.8
Weighted average number of common shares outstanding—diluted (in shares)  35.735.335.0 23.111.5  
Net loss  -49.4-68.7-74.8-166.5-166.4-175.9-183.1-192.0
    Comprehensive loss  -55.9-74.9  -166.6-175.9-183.1-191.9
   
Revenue from Contract with Customer, Product and Service [Extensible Enumeration]          

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy